Clinical Trial Update: Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS)

View source ↗

Summary

This completed clinical trial evaluated the efficacy and safety of Lucrin Depot (goserelin acetate) in men with advanced prostate cancer and lower urinary tract…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Lucrin Depot (Leuprorelin)

Snippet

Sponsor: Abbott | Conditions: Advanced Prostate Cancer, Lower Urinary Tract Symptoms | Status: COMPLETED | Results posted: 2012-01-06